Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase
- 1 November 2007
- journal article
- research article
- Published by Elsevier BV in Toxicology
- Vol. 241 (1-2), 92-97
- https://doi.org/10.1016/j.tox.2007.08.087
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Hydrogen sulfide as a novel nociceptive messengerPain, 2007
- Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?British Journal of Pharmacology, 2006
- Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammationThe FASEB Journal, 2006
- Hydrogen sulfide potentiates interleukin-1β-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 2006
- Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphideBiochemical and Biophysical Research Communications, 2006
- Murine cystathionine γ-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expressionBiochemical Journal, 2004
- Hydrogen sulfide: from the smell of the past to the mediator of the future?Trends in Pharmacological Sciences, 2003
- The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel openerThe EMBO Journal, 2001
- Hydrogen Sulfide Induces Cyclic AMP and Modulates the NMDA ReceptorBiochemical and Biophysical Research Communications, 2000
- The Possible Role of Hydrogen Sulfide as an Endogenous Smooth Muscle Relaxant in Synergy with Nitric OxideBiochemical and Biophysical Research Communications, 1997